Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Blood Advances|September 21, 2022
Patient perspectives on testing for clonal hematopoiesis of indeterminate potentialTal Sella, Geoffrey G Fell, Peter G Miller, et al.
The Israel Medical Association Journal : IMAJ|May 11, 2010
First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention centerBen Boursi, Hanan Guzner-Gur, Yaquv Mashich, et al.
European Journal of Internal Medicine|January 15, 2013
One stop screening for multiple cancers: the experience of an integrated cancer prevention centerTal Sella, Ben Boursi, Amira Gat-Charlap, et al.
Breast Cancer Research and Treatment|November 5, 2020
Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancerTal Sella, Shari I Gelber, Philip D Poorvu, et al.
Journal of the National Cancer Institute|December 7, 2023
Taxanes for the treatment of breast cancer during pregnancy: an international cohort studyAna S Ferrigno Guajardo, Bryan F Vaca-Cartagena, Erica L Mayer, et al.
Breast (Edinburgh, Scotland)|June 17, 2026
De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world studyTal Sella, Frederieke van Duijnhoven, Hans Wildiers, et al.
Breast (Edinburgh, Scotland)|December 12, 2025
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapyAyelet Shai, Hans Wildiers, Claudio Venieri, et al.
JNCI Cancer Spectrum|May 25, 2026
Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohortStefania Morganti, Se E Kim, Qingchun Jin, et al.
Cancer Research|July 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast CancerFrancisco Hermida-Prado, Yingtian Xie, Shira Sherman, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Pageof 6